Korman, N.J., Passeron, T., Gordon, K.B., Okubo, Y., Bagel, J., Sofen, H., Warren, R.B., Bhatia, N., Spelman, L., Winthrop, K., Hippeli, L., Kisa, R.M., Banerjee, S. and Thaçi, D. 2023. Deucravacitinib in plaque psoriasis: 2-year laboratory results from the phase 3 POETYK PSO program. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s119. DOI:https://doi.org/10.25251/skin.7.supp.119.